Teverelix DP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Teverelix DP, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer [Phase 2]